Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. is a medical technology company focused on developing and commercializing minimally invasive solutions for obstructive sleep apnea (OSA). Its primary product is the Inspire system, a neurostimulation technology that treats moderate to severe OSA by delivering mild electrical stimulation to the hypoglossal nerve, which helps maintain an open airway during sleep. The system includes a closed-loop feature that continuously monitors the patient's breathing and adjusts stimulation accordingly. The company serves patients in the United States and globally, aiming to provide a safe and effective alternative to traditional therapies like continuous positive airway pressure (CPAP) machines.

Inspire Medical Systems, Inc. is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol INSP. The company's financial reporting and stock trading are conducted in United States Dollars (USD). As a US-based company listed on a major American exchange, its stock is accessible to investors through brokerage accounts that trade on the NYSE. The use of USD makes it straightforward for domestic investors and also provides a benchmark for international investors who may need to consider currency exchange rates when evaluating the stock.

Inspire Medical Systems operates in the Healthcare sector, specifically within the Medical Devices industry. This means the company designs, manufactures, and sells medical devices that are used to diagnose, monitor, or treat medical conditions. In Inspire's case, its focus is on devices for obstructive sleep apnea, a common sleep disorder. The Medical Devices industry is highly regulated, requiring approvals from bodies like the FDA in the United States, and involves significant research and development to innovate and improve patient outcomes. Inspire's neurostimulation technology represents a specialized segment within this industry.

Inspire Medical Systems, Inc. is headquartered in Golden Valley, Minnesota, United States. The company was incorporated in 2007 and has since focused on the development and commercialization of its sleep apnea solutions. It serves patients in the United States and globally, indicating an international presence. While the headquarters is in Minnesota, the company likely has operations, sales, and distribution networks to support its global market. The specific countries outside the US are not detailed in the available data, but the company's description mentions serving both domestic and international markets.

Inspire Medical Systems generates revenue primarily through the sale of its Inspire system, a neurostimulation device for treating obstructive sleep apnea. The company's business model involves selling the implantable device and associated components to healthcare providers, such as hospitals and sleep clinics, which then implant the device in patients. Additionally, the company may earn revenue from ongoing services or support related to the device. As a medical technology company, its income is driven by the adoption of its minimally invasive solution by physicians and patients seeking alternatives to traditional OSA treatments. The company's focus on innovation and clinical evidence supports its commercial success.